Bp 2000 serie 2

Manufactured by Visitech

The BP-2000 Series II is a versatile lab equipment product designed for various applications. It features advanced functionalities and performance capabilities to meet the needs of research and testing environments. The detailed specifications and intended use of this product are not available in an unbiased and factual manner within the scope of this request.

Automatically generated - may contain errors

Lab products found in correlation

Spelling variants of this product

BP-2000 (126 citations) BP-2000 Series II (14 citations) BP-2000 series II Blood Pressure Analysis System (11 citations) BP-2000 series II instrument (2 citations)

2 protocols using bp 2000 serie 2

Tail-Cuff Blood Pressure Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols

The blood pressure analysis system (BP-2000 Serie II, Visitech Systems) was used to determine systolic blood pressure (SBP), by tail-cuff sphygmomanometry, twice weekly during 5 weeks. Prior to start of blood pressure monitoring, rats were trained daily for one week to get used to the system. Blood pressure was always monitored at 9 a.m and included at least 12 measurements.

Yao N.A., Niazi Z.R., Najmanová I., Kamagaté M., Said A., Chabert P., Auger C., Die-Kakou H, & Schini-Kerth V. (2020). Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats. Journal of cardiovascular pharmacology, 75(6).

+ Open protocol

+ Expand

Tail-Cuff Blood Pressure Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols

Systolic blood pressure was determined by tail-cuff sphygmomanometry twice weekly during 5 weeks using the blood pressure analysis system (BP-2000 Serie II, Visitech Systems). Prior to start of blood pressure monitoring, rats were trained daily for 1 week to get used to the system.

Park S.H., Farooq M.A., Gaertner S., Bruckert C., Qureshi A.W., Lee H.H., Benrahla D., Pollet B., Stephan D., Ohlmann P., Lessinger J.M., Mayoux E., Auger C., Morel O, & Schini-Kerth V.B. (2020). Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat. Cardiovascular Diabetology, 19, 19.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!